Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange

被引：19

作者：

Yagishita, Mizuki ^{[1
]}

Kondo, Yuya ^{[1
]}

Terasaki, Toshihiko ^{[1
]}

Terasaki, Mayu ^{[1
]}

Shimizu, Masan ^{[1
]}

Honda, Fumika ^{[1
]}

Oyama, Ayako ^{[1
]}

Takahashi, Hiroyuki ^{[1
]}

Yokosawa, Masahiro ^{[1
]}

Asashima, Hiromitsu ^{[1
]}

Hagiwara, Shinya ^{[1
]}

Tsuboi, Hiroto ^{[1
]}

Matsumoto, Isao ^{[1
]}

Sumida, Takayuki ^{[1
]}

机构：

[1] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan

来源：

INTERNAL MEDICINE | 2018年 / 57卷 / 13期

关键词：

clinically amyopathic dermatomyositis; interstitial lung disease; plasma exchange; ANTIBODY-POSITIVE DERMATOMYOSITIS; LUNG-DISEASE; AUTOANTIBODIES; HEMOPERFUSION; COMPLICATION; FERRITIN; CADM-140; COHORT; ADULT;

D O I：

10.2169/internalmedicine.0297-17

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with clinically amyopathic dermatomyositis (CADM), a subset of dermatomyositis characterized by a lack of muscle involvement, frequently develop rapidly progressive and treatment-resistant interstitial lung disease. We report the case of a 49-year-old man who was diagnosed with CADM. He developed interstitial pneumonia, which did not respond to combination therapy with methylprednisolone pulse therapy, cyclophosphamide, and cyclosporine. We therefore attempted plasma exchange. After 7 courses of therapeutic plasma exchange, the interstitial pneumonia gradually improved. This case suggests that plasma exchange might be an effective therapeutic option for patients with progressive interstitial lung disease in steroid- and immunosuppressive therapy-refractive CADM.

引用

页码：1935 / 1938

页数：4

共 50 条

[1] Therapeutic plasma exchange for clinically amyopathic dermatomyositis (CADM) associated with rapidly progressive interstitial pneumonia
Yamagata, Akira
Arita, Machiko
Tanaka, Ayaka
Tokioka, Fumiaki
Yoshida, Tomohiro
Nishimura, Keisuke
Ishida, Tadashi
JOURNAL OF CLINICAL APHERESIS, 2020, 35 (05) : 435 - 443
[2] A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy
Hiraoka, Daisuke
Ishizaki, Jun
Horie, Kenta
Matsumoto, Takuya
Suemori, Koichiro
Takenaka, Katsuto
Hasegawa, Hitoshi
MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (02) : 194 - 198
[3] Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series
Saito, Tomohiro
Mizobuchi, Masahide
Miwa, Yusuke
Sugiyama, Motonori
Mima, Yuuki
Iida, Ayana
Kanazawa, Nobuhiro
Morikawa, Tomoki
Hayashi, Junichi
Fukuda, Kei
Shikida, Yasuto
Suzuki, Taihei
Honda, Hirokazu
JOURNAL OF CLINICAL APHERESIS, 2021, 36 (01) : 196 - 205
[4] Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion
Kakugawa, Tomoyuki
Mukae, Hiroshi
Saito, Masataka
Ishii, Koji
Ishimoto, Hiroshi
Sakamoto, Noriho
Takazono, Takahiro
Fukuda, Yuichi
Ooe, Nobuharu
Kohno, Shigeru
INTERNAL MEDICINE, 2008, 47 (08) : 785 - 790
[5] A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
Takada, Toshinori
Asakawa, Katsuaki
Barrios, Roberto
CLINICAL RHEUMATOLOGY, 2021, 40 (03) : 1159 - 1165
[6] Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease
Kagitani, Maki
Nomi, Hayahito
Azuma, Haruhito
THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (01) : 152 - 158
[7] Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
Gan, Yu-Zhou
Zhang, Li-Hua
Ma, Lin
Sun, Feng
Li, Yu-Hui
An, Yuan
Li, Zhan-Guo
Ye, Hua
CHINESE MEDICAL JOURNAL, 2020, 133 (06) : 644 - 649
[8] Clinically amyopathic dermatomyositis
Sato, Shinji
Kuwana, Masataka
CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (06) : 639 - 643
[9] Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Rapidly Progressing Interstitial Lung Disease Successfully Treated by Initiation of Combined Immunosuppressive Therapy Plus Plasma Exchange and Subsequently Switching Tacrolimus to Tofacitinib
Yamazoe, Masami
Takeda, Kazuya
Nagano, Yutaro
Nagano, Kanami
Kato, Koji
Inoue, Takashi
Horiuchi, Kazuhiro
Kamada, Kazuro
INTERNAL MEDICINE, 2024, 63 (18) : 2571 - 2578
[10] Fibrocellular non-specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
Yoshizawa, Takahiro
Sugino, Keishi
Shibuya, Kazutoshi
Uekusa, Toshimasa
Homma, Sakae
RESPIROLOGY CASE REPORTS, 2016, 4 (05): : e1 - 4

← 1 2 3 4 5 →